Clinical Trial Update: Pharmacogenomics for Antidepressant Guidance and Education

View source ↗

Summary

Clinical trial on pharmacogenomics for antidepressant guidance and education in treatment-resistant depression was terminated with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Treatment Resistant Depression | Status: TERMINATED | Results posted: 2018-11-05